Orchestra BioMed:Chardan Capital maintains Buy, PT raised to $20 from $20.

jueves, 13 de noviembre de 2025, 9:08 am ET1 min de lectura
GFS--
OBIO--

Orchestra BioMed:Chardan Capital maintains Buy, PT raised to $20 from $20.

Orchestra BioMed:Chardan Capital maintains Buy, PT raised to $20 from $20.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios